Arcus Capital Partners’s CME Group CME Stock Holding History

Arcus Capital Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28	Closed	-$4.71K	–	161
2022 Q4	$4.71K	Buy	+28	New	+$4.87K	﹤0.01%	300

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Arcus Capital Partners's CME Position: Q1 2023 in Review

Arcus Capital Partners sold out of CME Group (CME) in Q1 2023, closing a stake of 28 shares — an estimated $4.71K sold.

Arcus Capital Partners first reported a position in CME in Q4 2022 and held it in 1 quarter. The position peaked at $4.71K in Q4 2022. 1,171 funds tracked by Wall St. Rank hold CME as of Q1 2023.

Arcus Capital Partners reported no remaining CME Group position as of Q1 2023 after selling out during the quarter.
Arcus Capital Partners sold 28 CME Group shares in Q1 2023, an estimated $4.71K.
Arcus Capital Partners first reported a position in CME Group in Q4 2022 and held it in 1 quarter.
Arcus Capital Partners's CME Group position peaked at $4.71K in Q4 2022.
1,171 funds tracked by Wall St. Rank held CME Group as of Q1 2023.

Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.